BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36749222)

  • 1. Bioinformatics identify the role of chordin-like 1 in thyroid cancer.
    Yu JW; Pang R; Liu B; Zhang L; Zhang JW
    Medicine (Baltimore); 2023 Feb; 102(5):e32778. PubMed ID: 36749222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma.
    Deng B; Chen X; Xu L; Zheng L; Zhu X; Shi J; Yang L; Wang D; Jiang D
    Aging (Albany NY); 2022 Jan; 14(1):389-409. PubMed ID: 35021154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
    Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
    Front Immunol; 2022; 13():964891. PubMed ID: 36059514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
    Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
    J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
    Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
    BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
    Shen Y; Dong S; Liu J; Zhang L; Zhang J; Zhou H; Dong W
    Biomed Res Int; 2020; 2020():9710421. PubMed ID: 32337286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis.
    Sun T; Guan Q; Wang Y; Qian K; Sun W; Ji Q; Wu Y; Guo K; Xiang J
    Gland Surg; 2021 Feb; 10(2):629-644. PubMed ID: 33708546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
    Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
    J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway.
    Yu ZX; Xiang C; Xu SG; Zhang YP
    Medicine (Baltimore); 2022 Aug; 101(31):e29972. PubMed ID: 35945747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma.
    Zhang MM; Zhao YD; Li Q; He YJ
    Histol Histopathol; 2023 Jun; 38(6):695-707. PubMed ID: 36409028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
    Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis
    Wu Q; Zheng Z; Zhang J; Piao Z; Xin M; Xiang X; Wu A; Zhao T; Huang S; Qiao Y; Zhou J; Xu S; Cheng H; Wu L; Ouyang K
    Front Oncol; 2022; 12():862751. PubMed ID: 35494000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer.
    Pei YF; Zhang YJ; Lei Y; Wu WD; Ma TH; Liu XQ
    Oncotarget; 2017 Apr; 8(14):23155-23166. PubMed ID: 28423564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.